acquired
Stage
3
Investors
About
Metsera is a clinical-stage biopharmaceutical company focused on developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions.
Explore Metsera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.